BTOG

Innovation drives progress. From clinical research to education, BTOG supports the lung cancer community in delivering better treatments and outcomes.
#LungCancerAwareness #LCSM #LungCancer

BTOG is excited to share the 1st Release Draft Programme for #BTOG26 (subject to faculty confirmations). #LCSM

btog.org/24th-btog-an...

Photo of Professor Sanjay Popat saying "Research is fundamental to providing state-of-the-art care." All about supporting life saving lung cancer research during LCAM.

Research isn’t separate from care - it is care.

As Professor @drsanjaypopat.bsky.social reminds us, advancing #lungcancer research is how we deliver the best possible treatment, outcomes & hope.

Support research. Share stories. Drive change.

#StoriesOfLungCancer #LCAM25 @btog.bsky.social

Early detection saves lives. Screening, research and collaboration are key to tackling lung cancer. BTOG is committed to advancing knowledge and improving care across the UK.
#LungCancerAwareness #LCSM #LungCancer

⏳ 1 week to go!
We’re nearly there — a full day on non-smoking lung cancer: from diagnosis to survivorship. With @ruthstraussfdn.bsky.social
Still time to register 👉
🔗 www.btog.org/non-smo...
📅 Thurs 13 Nov | 📍 London
#LungCancer #LCSM #NonSmokingLungCancer

Just out: ESMO Top 10 Abstracts Webcast & Podcast

The rationale and design, efficacy, side effects & potential impact with: @tnewsomdavis.bsky.social Dr Shobhit Baijal & Dr Sharmistha Ghosh.

Video webcast is members only, audio podcast open access.

Details: www.btog.org/esmo25-top10-webcast/

💭 What’s in a name?
Martin Forster opens the event exploring how we label non-smoking lung cancer — and why it matters.
📅 Join us 13 Nov, London
🔗 www.btog.org/non-smo...

#Oncology #LungCancer

New #podcast release:

BTOG does … Chemo RT: What to do in unresectable disease

Dr Emma O'Dowd talks to Dr Clive Peedell, Consultant Clinical Oncologist, James Cook University Hospital.

Search BTOG in App Store/Spotify/Amazon Music or listen via BTOG website www.btog.org/btog-po...

#LCSM

✅ CPD credits (applied for)
✅ Patient voice
✅ Groundbreaking science
🎟️ Join the BTOG Non-Smoking Lung Cancer Essential Update with @ruthstraussfdn.bsky.social
📅 13 Nov, London
🔗 www.btog.org/non-smo...
#LungCancer #LCSM #NonSmokingLungCancer

BTOG wishes to inform members of a new @nicecomms.bsky.social release published today.

NICE has recommended Lorlatinib as an option for ALK-positive advanced non-small-cell lung cancer in adults who have not had an ALK inhibitor.

More details
www.nice.org.uk/guidance/TA1...

#LCSM #LungCancer

👥 Meet the experts:
🧑‍⚕️ @tnewsomdavis.bsky.social
🧑‍⚕️ Martin Forster
and many more with @ruthstraussfdn.bsky.social at #NonSmokingLungCancer.
A full day of learning and networking awaits.
📆 13 Nov
🔗 www.btog.org/non-smo...
#LungCancer #LCSM #NonSmokingLungCancer

Screening Event
🎉 Today’s the day!
The #BTOGScreeningEvent kicks off in London with vital updates on #LungCancer screening across the UK.
We’ll be talking strategy, challenges, and the future of screening.
Follow along and join the conversation ⬇️ #BTOGScreeningEvent
#LCSM

NLCA Newsletter, October 2025 - National Cancer Audit Collaborating Centre We use some essential cookies to make this website work.

The October NLCA newsletter is out now! Read about our QI intervention, upcoming State of the Nation report and more…!
www.natcan.org.uk/news/nlca-ne...

@hqip.bsky.social @btog.bsky.social
#LungCancer

The NLCA October quarterly data dashboard is now live! This includes the latest English data up to 31 Dec 2024:
rcs-ceu.shinyapps.io/NLCA/

@hqip.bsky.social @btog.bsky.social #LungCancer

We’re ready. Are you?
👥 Meet national experts
🧠 Debate real-world screening issues
🗣️ Submit your questions live
📍London | ⏰ Doors open 08:30
See you tomorrow at the #BTOGScreeningEvent
#LungCancer #LCSM

💡 Discover the latest in mutation-driven lung cancer research.
Session 4 with @ruthstraussfdn.bsky.social rings science, debate, and progress together.
📅 13 Nov | 📍 The View, London
🔗 www.btog.org/non-smo...
#LungCancer #LCSM #NonSmokingLungCancer

1 week to go!
⏳ The #BTOGScreeningEvent is almost here. Join the lung cancer screening community in London for vital updates, peer discussions, and practical challenges.
Don’t miss it — register today: www.btog.org/btog-sc...
#LungCancer #LCSM

"🧩 Local Consolidative Therapy – survival benefits or overtreatment?
Hear from experts tackling difficult questions in non-smoking lung cancer.
🎫 Register today
🔗 www.btog.org/non-smo...
#LungCancer #LCSM #NonSmokingLungCancer
With @RuthStraussFdn"

Registration and abstract submissions are now open for #BTOG26 our 24th Annual Conference, which will be held at the EICC in Edinburgh.

Full details are on the website www.btog.org/24th-btog-an...

#LCSM #lungcancer

Ruth Strauss Foundation have grants up to £50,000 available for research into Non-Smoking #LungCancer; to improve understanding, diagnosis & quality of life 🫁

🗓️ Apply by 10 Jan 2026 #LCSM

ruthstraussfoundation.com/grants-progr...

Perioperative Nivolumab Proves Safe, Effective for Patients with Resectable Early-Stage NSCLC - ILCN.org (ILCN/WCLC) Dr. Jonathan Spicer shared patient-reported outcomes data from CheckMate 77T showing the regimen is both safe and tolerable for patients.

♟️ CheckMate for perioperative nivolumab? Dr. Jonathan Spicer presented the latest data from the CheckMate 77T trial at #WCLC25.

🔗 Read more in ILCN: bit.ly/46m612v

"Psychological distress in screening is real.
How can we recognise & manage it effectively?
Join the discussion at #BTOGScreeningEvent
✅ Full programme: www.btog.org/btog-sc...
#LungCancer #LCSM
"

"🔍 Brain metastases + the DVLA – treatment implications for your practice.
Don’t miss this timely session in our Advanced Disease module.
📍 London | 📅 13 Nov
#LungCancer #LCSM #NonSmokingLungCancer
🔗 www.btog.org/non-smo...
with @RuthStraussFdn"

"Peer support is vital in lung cancer screening delivery.
Our fireside chat will feature first-hand insights from teams on the ground — with real-world Q&A from attendees.
🗓️ 14 Oct 2025 | 💬 Bring your questions!
#LungCancer #LCSM #BTOGScreeningEvent
"

"🧠 MRD: Molecular Residual Disease – is it ready for clinical use in early NSCLC?
Get the latest on 13 Nov with @RuthStraussFdn.
🔗 www.btog.org/non-smo...
#LungCancer #LCSM #NonSmokingLungCancer"

New Podcast Alert!

BTOG does … Neo-adjuvant / peri-operative chemoimmunotherapy

@tnewsomdavis.bsky.social & Emma O'Dowd talk to Jason Adhikaree.

Subscribe via Apple App Store, Spotify or Amazon Music – just search BTOG or listen via the BTOG website.
www.btog.org/btog-podcasts/
#LCSM #lungcancer

"Just 4 weeks to go!
Ready to debate hot topics in #LungCancer screening?
Our quick-fire debate session features rapid PRO/CON talks on controversial issues — don’t miss it.
Register now 👉 www.btog.org/btog-sc...
#LCSM #BTOGScreeningEvent
"

Durvalumab can only be used if the company provides it according to the commercial arrangement.

For full details and the documents, please see the NICE website www.nice.org.uk/guidance/gid...

BTOG wishes to inform members of a new NICE release that has been published today.

NICE has recommended Durvalumab, within its marketing authorisation, as an option to treat limited-stage small-cell lung cancer that has not progressed after platinum-based chemoradiotherapy in adults.
#LCSM

NLCA Patient Guide to Statistics - National Cancer Audit Collaborating Centre This guide is intended to help patients and the public better understand the numbers and statistics used by the National Lung Cancer Audit to report lung cancer care.

📢NLCA has launched a brand new Patient Guide to Statistics📊
This guide is designed to help patients, carers, and the public better understand the numbers and data used by the Audit.
🔗Check it out here: www.natcan.org.uk/library/nlca...

@hqip.bsky.social @btog.bsky.social
#LungCancer #ClinicalAudit